When will the new drug for MS be approved and when can I take it?
I believe you are referring to Ocrelizumab (Brand Name OCREVUS) in your question. The PDUFA date (this stands for Prescription Drug User Fee Act) is March 28, 2017. This is the date by which the FDA must make a decision as to whether they will approve OCREVUS. This date is not set in stone and the FDA is allowed to extend the date for valid reasons. They already extended the OCREVUS PDUFA date from December 28, 2016 to March 28, 2017, so we are hoping there will be no further delays.
Revere (Rip) Kinkel MD
Professor of Clinical Neurosciences
Director of the Multiple Sclerosis Program
Clinical Neurosciences Director
University of California San Diego